Furthermore, serum LAPTM4B levels were positively correlated with smoking, advanced clinical stages, lymph node metastasis, ALK rearrangements and EGFR mutations. The gene discussed is LAPTM4B; the disease is metastatic malignant neoplasm in the lymph nodes.